The Charles Bronfman Institute for Personalized Medicine
The mission of The Charles Bronfman Institute for Personalized Medicine is to personalize disease risk assessment and improve responsiveness to treatments for patients through innovative translational genomics and genetics research. Additionally, through our research, our goal is to pioneer new advancements in healthcare for patients and providers through the delivery of personalized data-driven clinical care. Personalized data-driven care encompasses ALL patient-unique types of data, including information about DNA and personal genome, molecules and biomarkers, clinical and family health, as well as personal health information.
Your history is our future.
BioMe: Channeling the power of genomics and BIG data to elevate medical decision-making and optimize the customization of healthcare.
1468 Madison Avenue
(at E. 101st Street)
18th Floor, Room 18-16
New York, NY 10029
We are at the dawn of a revolution in healthcare where the integration of genomics and deep clinical data will usher in a new era of data-driven personalized healthcare. Read More